Phase II trial of imatinib mesylate in patients with metastatic melanoma

8/20/2008 From British Journal of Cancer AOP

Summary:
Phase II trial of imatinib mesylate in patients with metastatic melanoma
British Journal of Cancer advance online publication, August 19, 2008. doi:10.1038/sj.bjc.6604482
Authors: K B Kim, O Eton, D ...

Original link:http://dx.doi.org/10.1038/sj.bjc.6604482

Bookmark | Comment | Forward | Twitter |

More articles from British Journal of Cancer AOP

VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma 2008-10-31 22:06
Lung cancer screening: the way forward 2008-10-31 22:06
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer 2008-10-31 22:06
VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis 2008-10-01 04:48
Endometrial stromal sarcoma: a population-based analysis 2008-09-24 16:11
‘Population mixing, socio-economic status and incidence of childhood acute lymphoblastic leukaemia in England and Wales – analysis by census ward’ and ‘Childhood leukaemia and population movements in France, 1990–2003’ 2008-09-23 22:37
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer 2008-09-03 05:16
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy 2008-09-03 05:15

Comments:

- Comments

Username: Login Sign Up

What's fun in inezha?

Track your favorite blogs
Just-in-time notification
Web-based RSS reader
Share your subscriptions